US Broker Ratings

Arbutus Biopharma Corporation (ABUS) Stock Analysis: A High-Potential Biotech with 522% Revenue Growth

Arbutus Biopharma Corporation (NASDAQ: ABUS) presents a compelling opportunity for investors looking to tap into the high-growth potential of the biotechnology sector. With a market capitalization of $927.82 million and..

Replimune Group, Inc. (REPL) Stock Analysis: Eyeing a 3.66% Upside in the Biotech Sector

Replimune Group, Inc. (NASDAQ: REPL) has been catching the attention of investors with its promising oncolytic immunotherapies targeting cancer treatment. As a clinical-stage biotechnology company headquartered in Woburn, Massachusetts, Replimune..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a Potential 74% Upside

AbCellera Biologics Inc. (ABCL), a prominent player in the biotechnology sector, is making waves with its innovative approach to antibody-based medicine. Headquartered in Vancouver, Canada, the company is renowned for..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A Biotech Play with 180% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a burgeoning player in the biotechnology sector, presents an intriguing opportunity for investors with a risk appetite and a keen eye on the healthcare market...

Dianthus Therapeutics, Inc. (DNTH) Rating Update: Analyst Consensus Suggests 84.15% Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a promising player in the biotechnology sector, is attracting investor attention with a market capitalization of $1.34 billion. This clinical-stage company, headquartered in New York,..

Simulations Plus, Inc. (SLP) Stock Analysis: A Hidden Gem in Healthcare with 34% Upside Potential

Simulations Plus, Inc. (NASDAQ: SLP), a leader in the healthcare sector, is carving out a niche with its innovative drug discovery and development software solutions. With a market capitalization of..

LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a 121.98% Potential Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) is stirring interest in the healthcare sector with its innovative approach to telehealth services. With a market capitalization of $275.02 million, LifeMD stands out in the..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges with Strategic Collaborations in Molecular Diagnostics

Myriad Genetics, Inc. (NASDAQ: MYGN) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. As a molecular diagnostic testing and precision medicine company, Myriad..

Cel-Sci Corporation (CVM) Investor Outlook: Unveiling a Massive 2,611% Potential Upside in Biotechnology

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors with its staggering potential upside of 2,611.07%, a figure that stands out in the high-stakes world of biotechnology. As a..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Analyzing a 46.59% Potential Upside in Pediatric Orthopedic Innovation

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, particularly within the medical devices industry, as a unique player focused on pediatric orthopedic solutions. Headquartered in Warsaw, Indiana, the..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 116% Potential Upside in Healthcare Innovation

Bioventus Inc. (NASDAQ: BVS), a key player in the medical devices sector, stands as a noteworthy investment candidate for those eyeing substantial growth potential within the healthcare industry. With its..

Neuropace, Inc. (NPCE) Stock Analysis: Unlocking a Potential 69.88% Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) stands as a compelling opportunity, especially with a notable potential upside of 69.88% based on the..

Semler Scientific, Inc. (SMLR) Stock Analysis: Unpacking the 206% Potential Upside for Investors

Semler Scientific, Inc. (NASDAQ: SMLR) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $372.73 million, this Santa Clara-based company is..

Personalis, Inc. (PSNL) Investor Outlook: Navigating a Tumultuous Market with Innovative Genomic Solutions

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly in diagnostics and research, with its cutting-edge cancer genomic tests and services. Even as the company grapples with..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unlocking a 25% Upside with Robust Revenue Growth

For investors looking to tap into the healthcare sector’s promise, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling opportunity. This specialty pharmaceutical company is making significant strides in the development..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem with Over 100% Potential Upside

Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is captivating investor attention with its innovative approach to gene and cell therapy. Headquartered in Germantown, Maryland, this biopharmaceutical..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 74.83% Potential Upside in Healthcare Tech

Investors looking for opportunities in the health information services sector may want to consider Weave Communications, Inc. (NYSE: WEAV). With a market capitalization of $503.05 million, Weave is carving out..

MeiraGTx Holdings plc (MGTX): Investor Outlook Reveals a Potential 215% Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its ambitious approach to genetic medicine. Specializing in innovative therapies for..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring a 246.85% Potential Upside in Biotechnology

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector for its promising portfolio of therapies targeting autoimmune diseases and cancer. Based in Cambridge,..

Arvinas, Inc. (ARVN) Stock Analysis: Assessing an 81.27% Potential Upside in the Biotechnology Sector

Arvinas, Inc. (NASDAQ: ARVN) is a name that has been generating interest among investors, particularly in the healthcare sector, where innovation often leads to significant stock value appreciation. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds